ADALTA LIMITED

1AD

equity

AUD $0.040

0.00 (0%)

Updated: 20 Jan, 5:10 am UTC

Description

Adalta Limited is an ASX-listed biotechnology company focused on the development of innovative therapies for the treatment of chronic diseases. Adalta’s core objective is to develop innovative antibody-based therapies for the prevention and treatment of chronic diseases such as inflammation, fibrosis and cancer. The company’s current operations include, a Phase 2 clinical study of its lead product, AD-114, a novel anti-PD-L1 antibody for the treatment of solid tumours, and pre-clinical programs for other novel antibodies targeting inflammatory diseases, fibrosis and cancer.

Activity
Last price		$0.040
Change		0.00 (0%)
Bid/Ask		$0.039 - $0.040
Volume		106,811.00
Volume traded/total %		0.034%
Volume avg (4w)		147,307.00
Open		$0.040
Day range		$0.039 - $0.040
Previous Close		$0.040
Last Trade		20 Jan, 5:10 am UTC

Size
Market Cap		$12.57M
Market Rank		2198
Industry Rank		91

Fundamentals
Shares Issued		314.18M
Earnings Per Share (EPS)		$-0.022
Dividends Per Share (DPS)		-
P/E Ratio		-

Similar to